Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not
readily achievable with currently approved doses. There is limited evidence to support its …

Importance Ivermectin is widely prescribed as a potential treatment for COVID-19 despite
uncertainty about its clinical benefit. Objective To determine whether ivermectin is an …

Introduction In vitro studies have shown the efficacy of Ivermectin (IV) to inhibit the SARS—
CoV-2 viral replication, but questions remained as to in-vivo applications. We set out to …

Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively
reviewed severe COVID-19 patients receiving standard doses of ivermectin and we …

Objectives In this randomized open-label trial pilot study we assessed the antiviral effects
and safety of various doses of ivermectin in patients with mild clinical symptoms of COVID …

High concentrations of ivermectin demonstrated antiviral activity against SARS-CoV-2 in
vitro. The aim of this study was to assess the safety and efficacy of high-dose ivermectin in …

Objective Ivermectin has been suggested as a treatment for COVID-19. This randomised
control trial was conducted to test the efficacy of Ivermectin in the treatment of mild and …

Background There are limited antiviral options for the treatment of patients with COVID-19.
Ivermectin (IVM), a macrocyclic lactone with a wide anti-parasitary spectrum, has shown …

Purpose Given the coronavirus disease 2019 (COVID-19) pandemic, there is a global
urgency to discover an effective treatment for patients withthis disease. This study aimed to …

Objective: This study was designed to determine the efficacy of ivermectin, an FDA-
approved drug, in producing clinical benefits and decreasing the viral load of SARS-CoV-2 …